1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ALIVUS LIFE SCIENCES LTD.
Alivus Life Sciences Ltd.
NSE: ALIVUS | BSE: 543322

Alivus Life Sciences Live Share Price Today, Share Analysis and Chart

Turnaround Potential
about

Alivus Life Sciences Ltd. (formerly Glenmark Life Sciences Ltd.) is a manufacturer and developer of high-value, non-commoditized Active Pharmaceutical Ingredients (APIs). The company focuses on chronic therapeutic areas, including cardiovascular dise...

Read More
Iran War Impact
Ask MarketMind AI
1121.30 0.20 (0.02%)
36.91% Gain from 52W Low
67,490
NSE+BSE Volume

NSE 08 May, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Alivus Life Sciences is on 14 May 2026 for the purpose of Audited Results & Final Dividend See details
Loading... You have run out of DVM views!
Subscribe now to see details
Durability score
Medium Financial Strength
- / 100
Valuation Score
Mid Valuation
- / 100
Momentum Score
Technically Moderately Bullish
66.1 / 100
Turnaround Potential These stocks have average financials and valuation, but strong momentum indicating buying interest View Similar Embed DVM
Analyst Price Target
1,158
1Yr Price target upside is 3%
3 analysts

19

S

6

W

6

O

3

T

SWOT Analysis

Alivus Life Sciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
VOTE: Is Glenmark Life Sciences Ltd. worth buying?
133 Votes:
Buy 75.19%
Sell 12.03%
Hold 12.78%
BUY
SELL
HOLD
Ask AI